Hepatic neuroendocrine metastases: chemo- or bland embolization? (Q35930191)

11 August 2017

Hepatic neuroendocrine metastases: chemo- or bland embolization? (English)

1 reference

11 August 2017

5

Sharon M Weber

1 reference

11 August 2017

Susan C Pitt

1

1 reference

11 August 2017

Jaime Knuth

2

1 reference

11 August 2017

James M Keily

3

1 reference

11 August 2017

John C McDermott

4

1 reference

11 August 2017

Hebert Chen

6

1 reference

11 August 2017

William S Rilling

7

1 reference

11 August 2017

Edward J Quebbeman

8

1 reference

11 August 2017

David M Agarwal

9

1 reference

11 August 2017

Henry A Pitt

10

1 reference

11 August 2017

16 August 2008

1 reference

Journal of Gastrointestinal Surgery

11 August 2017

1 reference

11 August 2017

12

1 reference

11 August 2017

1951-1960

1 reference

11 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-008-0640-6

11 August 2017

0 references

cites work

Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Gastroenteropancreatic neuroendocrine tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

New drug development in digestive neuroendocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Current management of gastrointestinal carcinoid tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Ablative therapies for liver metastases of digestive endocrine tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Gastrointestinal carcinoids. Prognosis and survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

The clinical use of gastrointestinal hormones for alimentary tract disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic arterial chemoembolization for metastatic endocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

The management of patients with advanced carcinoid tumors and islet cell carcinomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic arterial chemoembolization for metastatic neuroendocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Transcatheter chemoembolization of progressive carcinoid liver metastasis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Embolization of the liver in the management of metastatic carcinoid tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic arterial embolisation in patients with metastatic carcinoid tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Hepatic neuroendocrine metastases: does intervention alter outcomes?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Prognosis and survival in patients with gastrointestinal tract carcinoid tumors

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342849

Neuroendocrine hepatic metastases: does aggressive management improve survival?

14 November 2018

1 reference

12 December 2020

A Phase II Study of Irinotecan with 5-Fluorouracil and Leucovorin in Patients with Pretreated Gastroenteropancreatic Well-Differentiated Endocrine Carcinomas

1 reference

12 December 2020

Metastatic neuroendocrine hepatic tumors: resection improves survival

1 reference

12 December 2020

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

1 reference

12 December 2020

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors

1 reference

12 December 2020

Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumors

1 reference

12 December 2020

Hepatic artery embolization for treatment of endocrine gastrointestinal tumors with liver metastases

1 reference

12 December 2020

Prognostic variables in patients with gastrointestinal carcinoid tumours

1 reference

12 December 2020

Hepatic resection for metastatic neuroendocrine carcinomas

1 reference

12 December 2020

Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumors

1 reference

12 December 2020

Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors

1 reference

12 December 2020

Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?

1 reference

12 December 2020

10.1007/S11605-008-0640-6

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference